Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.59) by 6.78 percent. This is a 60.87 percent increase over losses of $(1.61) per share from the same period last year.
Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.59) by 6.78 percent. This is a 60.87 percent increase over losses of $(1.61) per share from the same period last year.
Comments